What is MindOverMatteR's primary focus?

MindOverMatteR focuses on revolutionizing anxiety treatment through AI-powered neuromodulation therapies, integrating advanced neuroscience and technology.

When was MindOverMatteR founded?

MindOverMatteR was founded in May 2019.

Who is the founder of MindOverMatteR?

Lilach Roth is the founder and CEO of MindOverMatteR.

What is the operational status of MindOverMatteR?

MindOverMatteR is currently Non Active and ceased to operate in May 2022.

Which industries does MindOverMatteR serve?

MindOverMatteR aims to serve insurers, healthcare providers, and employers with its anxiety treatment solutions.

MindOverMatteR

AI-powered Neuromodulation Therapies for Anxiety Treatment

Health Tech & Life Sciences

Non Active, May 2022 ceased to operate

Company Overview

Snapshot

Founded in May 2019 by Lilach Roth, MindOverMatteR operates with 1–10 employees. The company is currently in a Pre-Funding stage.

Business overview

MindOverMatteR is a bioelectronic medicine startup focused on developing AI-powered neuromodulation therapies for anxiety treatment. The company integrates advanced neuroscience and technology to provide solutions for insurers, providers, and employers, aiming to transform anxiety management and build resilience while reducing healthcare expenses. MindOverMatteR operates within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics, leveraging Artificial Intelligence.

Company Intelligence Q&A

What is MindOverMatteR's primary focus?: MindOverMatteR focuses on revolutionizing anxiety treatment through AI-powered neuromodulation therapies, integrating advanced neuroscience and technology.
When was MindOverMatteR founded?: MindOverMatteR was founded in May 2019.
Who is the founder of MindOverMatteR?: Lilach Roth is the founder and CEO of MindOverMatteR.
What is the operational status of MindOverMatteR?: MindOverMatteR is currently Non Active and ceased to operate in May 2022.
Which industries does MindOverMatteR serve?: MindOverMatteR aims to serve insurers, healthcare providers, and employers with its anxiety treatment solutions.

After more than a decade of building and operating Finder as a resource for Israel’s technology ecosystem, Startup Nation Central concluded its operation of Finder on August 31, 2026.

It is important to us that the data and knowledge built through Finder remain available to serve the ecosystem. We are working to enable access to Israeli technology ecosystem data beyond SNC’s operation of Finder.

Registered Finder users will receive further updates by email. Confirmed updates will also be published on this page.

If you have any questions or would like to get in touch regarding Finder, please contact us at [email protected].

Thank you to the users, companies, and partners who have been part of Finder’s journey.

Name	MindOverMatteR
One-liner	AI-powered Neuromodulation Therapies for Anxiety Treatment
Type	Startup
Primary sector	Health Tech & Life Sciences
Founded	2019
Employees	1-10
Employees (exact)	6
HQ / location	Kefar Sava, Kfar Saba, Israel, Center District
Product stage	Customer development

Sectors	Health Tech & Life Sciences, Medical Devices, Medical Treatment & Therapeutics
Core technology	Artificial Intelligence
Target customers	Healthcare & Life Sciences, Healthcare, Insurance Companies, Providers
Business models	B2B
Tags	stealthmode, medical-devices, enterprises, healthcare-providers, neuroscience, mental-health, artificial-intelligence, insurance-companies